Insights into human health from phenome- and genome-wide analyses of UK Biobank retinal optical coherence tomography phenotypes

Seyedeh M. Zekavat, Saman Doroodgar Jorshery, Yusrah Shweikh, Katrin Horn, Franziska G. Rauscher, Sayuri Sekimitsu, Satoshi Kayoma, Yixuan Ye, Vineet K. Raghu, Hongyu Zhao, Marzyeh Ghassemi, Tobias Elze, Ayellet V. Segrè, Janey L. Wiggs, Markus Scholz, Lucian Del Priore, Jay Wang, Pradeep Natarajan, Nazlee ZebardastmedRxiv 2023 · DOI

Introduction

The human retina is a highly stratified extension of the central nervous system, offering a unique, non-invasive window into the body’s systemic health. While clinicians have long suspected that retinal changes mirror broader physiological conditions, the lack of high-resolution, large-scale data has historically limited our ability to map specific retinal layers to the "phenome" (the sum of observable traits and diseases) and the "genome."

In a landmark study, researchers utilized macular optical coherence tomography (OCT) images from 44,823 UK Biobank participants to conduct the largest-ever analysis of retinal layer thicknesses. By integrating automated imaging, longitudinal health records, and genetic data, the study identifies the retina as a potent biomarker for systemic disease risk, frailty, and mortality.

Methodology

The research team employed a multi-modal approach to decode the relationship between retinal structure and health:

  1. Automated Segmentation: Using the Topcon Advanced Boundary Segmentation (TABS) algorithm, the team measured nine distinct retinal layers from OCT scans, providing micron-scale resolution of the retinal architecture.
  2. Phenome-Wide Association Study (PheWAS): These measurements were associated with 1,866 incident ICD-based conditions (with a median 10-year follow-up) and 88 quantitative traits, including blood biomarkers and lung function.
  3. Genome-Wide Association Study (GWAS): The study scanned over 13 million genetic variants to identify the inherited markers influencing retinal thickness, replicating these findings in an independent cohort of 6,313 individuals from the LIFE-Adult Study.
  4. Causal Inference: Using Polygenic Risk Scores (PRS) and Mendelian Randomization, the researchers investigated whether systemic conditions cause retinal thinning or if the thinning serves as a precursor to disease.

Key Findings

One of the study's most striking discoveries is the direct association between retinal thinning and incident mortality. Thinning of the Photoreceptor Segment (PS) and the Ganglion Cell Complex (GCC) was found to predict a higher risk of death over a 10-year period. This association remained significant even after adjusting for traditional risk factors such as age, smoking status, and blood pressure. Specifically, each standard deviation of thinning in the PS layer was associated with a Hazard Ratio (HR) of 1.16 for mortality.

Layer-Specific Disease Associations

The study revealed that different retinal layers serve as markers for different health outcomes:

  • Retinal Nerve Fiber Layer (RNFL): Thinning in this layer is a primary hallmark of glaucoma.
  • Photoreceptor Segment (PS): Thinning here is closely tied to Age-Related Macular Degeneration (AMD) and systemic metabolic and pulmonary health.
  • Systemic Conditions: Significant associations were detected between retinal thinning and a broad spectrum of conditions, including neuropsychiatric disorders (Multiple Sclerosis, epilepsy, schizophrenia), cardiometabolic diseases (hypertension, heart failure, myocardial infarction), and pulmonary issues (COPD and asthma).

The GWAS identified 259 independent genetic loci associated with retinal layer thickness. Furthermore, the study identified 11 genes where rare, disruptive mutations significantly impact retinal structure (e.g., IMPG2).

Crucially, the findings suggest a bidirectional relationship between the retina and systemic health. While retinal thinning can predict future disease, systemic conditions—such as poor lung function (low FEV1) and high BMI—appear to genetically and epidemiologically drive the thinning of the photoreceptor layer. This reinforces the concept of the retina as a "biological clock" or a "retinal age" gap, where a thinner-than-expected retina signals advanced systemic aging or frailty.

Clinical Implications and Future Directions

The integration of retinal OCT measurements into Electronic Health Records (EHRs) could revolutionize clinical risk prediction. By identifying individuals with accelerated retinal thinning, clinicians may be able to intervene earlier in the progression of both ocular and systemic diseases.

However, the study notes limitations, primarily the lack of ethnic diversity, as the UK Biobank cohort is predominantly of European descent. Future research must validate these biomarkers across diverse global ancestries and investigate whether improving systemic health—through lifestyle changes or medical intervention—can slow the rate of retinal thinning and, by extension, improve long-term health outcomes.

Summary updated

Abstract

The human retina is a complex multi-layered tissue which offers a unique window into systemic health and disease. Optical coherence tomography (OCT) is widely used in eye care and allows the non-invasive, rapid capture of retinal measurements in exquisite detail. We conducted genome- and phenome-wide analyses of retinal layer thicknesses using macular OCT images from 44,823 UK Biobank participants. We performed phenome-wide association analyses, associating retinal thicknesses with 1,866 incident ICD-based conditions (median 10-year follow-up) and 88 quantitative traits and blood biomarkers. We performed genome-wide association analyses, identifying inherited genetic markers which influence the retina, and replicated our associations among 6,313 individuals from the LIFE-Adult Study. And lastly, we performed comparative association of phenome- and genome- wide associations to identify putative causal links between systemic conditions, retinal layer thicknesses, and ocular disease. Independent associations with incident mortality were detected for photoreceptor thinning and ganglion cell complex thinning. Significant phenotypic associations were detected between retinal layer thinning and ocular, neuropsychiatric, cardiometabolic and pulmonary conditions. Genome-wide association of retinal layer thicknesses yielded 259 loci. Consistency between epidemiologic and genetic associations suggested putative causal links between thinning of the retinal nerve fiber layer with glaucoma, photoreceptor segment with AMD, as well as poor cardiometabolic and pulmonary function with PS thinning, among other findings. In conclusion, retinal layer thinning predicts risk of future ocular and systemic disease. Furthermore, systemic cardio-metabolic-pulmonary conditions promote retinal thinning. Retinal imaging biomarkers, integrated into electronic health records, may inform risk prediction and potential therapeutic strategies.
BibTeX
@misc{zekavat2023insights,
  author = {Seyedeh M. Zekavat and Saman Doroodgar Jorshery and Yusrah Shweikh and Katrin Horn and Franziska G. Rauscher and Sayuri Sekimitsu and Satoshi Kayoma and Yixuan Ye and Vineet K. Raghu and Hongyu Zhao and Marzyeh Ghassemi and Tobias Elze and Ayellet V. Segrè and Janey L. Wiggs and Markus Scholz and Lucian Del Priore and Jay Wang and Pradeep Natarajan and Nazlee Zebardast},
  title = {{Insights into human health from phenome- and genome-wide analyses of UK Biobank retinal optical coherence tomography phenotypes}},
  year = {2023},
  doi = {10.1101/2023.05.16.23290063},
  howpublished = {medRxiv},
}
Figure